Insiders Chemomab Therapeutics Ltd.

Equities

CMMB

US16385C1045

Market Closed - Nasdaq Other stock markets 21:00:00 13/05/2024 BST			5-day change	1st Jan Change
0.814 ^USD	-2.98%		-4.55%	+59.61%

05-06	Oppenheimer Upgrades Chemomab Therapeutics to Outperform	MT
04-10	Transcript : Chemomab Therapeutics Ltd. - Special Call

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chemomab Therapeutics Ltd. Appoints Nissim Darvish, MD, PhD, as Chairman of the Board Effective June 1, 2023	05/06/23	CI
Chemomab Therapeutics Announces Appointment of Sigal Fattal as Chief Financial Officer Effective June 1, 2023	05/06/23	CI
Chemomab Therapeutics Ltd. Names Adi Mor, Phd as CEO	05/06/23	CI
Chemomab Announces Appointment of Mitchell L. Jones, as Vice President of Corporate Development & Strategy	30/11/22	CI
Insider Sell: Chemomab Therapeutics	17/11/22	MT
Chemomab Therapeutics Ltd. Appoints Matthew Frankel as Chief Medical Officer and Vice President of Drug Development	14/11/22	CI
Chemomab Therapeutics Ltd. Appoints Jill M. Quigley, JD to its Board of Directors	21/06/22	CI
Chemomab Therapeutics Ltd. Announces Joel Maryles Will Not Stand for Re-Election as Member of its Board of Directors	01/06/22	CI
Chemomab Therapeutics to Appoint CEO Dale Pfost as Chairman	16/12/21	MT
Chemomab Therapeutics Ltd. Announces Management Changes	16/12/21	CI
Chemomab Therapeutics Hires Dr. David Weiner as Interim Chief Medical Officer	03/12/21	MT
Chemomab Therapeutics Ltd. Announces Executive Changes	03/12/21	CI
Chemomab Therapeutics Names Donald Marvin as CFO, COO	08/11/21	MT
Chemomab Therapeutics Ltd. Names Donald R. Marvin, Executive Vice President and Chief Operating Officer	08/11/21	CI
Chemomab Therapeutics Ltd. Names Donald R. Marvin as Chief Financial Officer	08/11/21	CI
Chemomab Therapeutics : Names Dale Pfost Chief Executive	02/09/21	MT
Chemomab Therapeutics Ltd. Announces Management Changes	02/09/21	CI
Chemomab Therapeutics, Ltd. Announces Board Appointments	29/03/21	CI
Anchiano Therapeutics Ltd Announces Management Changes	17/03/21	CI
Anchiano Therapeutics Ltd Announces Executive Changes	17/03/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Chemomab Therapeutics Ltd.

Equities

CMMB

US16385C1045

Insiders

Filters